Two months after a key FDA panel voted down Merck’s conditional nod for Keytruda as a third-line treatment for certain stomach cancer patients, the company says it’s pulling the plug on the indication. Following consultation with the FDA, Merck on Thursday said it will voluntarily withdraw its U.S. accelerated approval for Keytruda as a third-line… Read More »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »
Author Marry Hall Published April 22, 2021 Word count 513 Facial skin more than often doesn’t get the attention and care that it really deserves. While everyone deals with a different skin type that needs an equally different care regime, people usually fail to understand this fact and tend to go for generalized treatment packages… Read More »
WEDNESDAY, April 21, 2021 — The COVID-19 pandemic may have kept some Americans from getting vital medication to treat opioid addiction — possibly contributing to the national surge in overdose deaths, a new study suggests. Researchers found that in the early months of U.S. pandemic restrictions, the number of Americans newly receiving prescriptions for buprenorphine… Read More »
A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »
How many of us have avoided a person for having foul breath? It is natural for people to shoo away someone whose breath has a foul odor. Probably we think the person in question doesn’t earn enough to buy toothpaste. Have we ever stopped to think whether the person is suffering from some chronic liver… Read More »
FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication… Read More »